Physician profile
John L Stone
NPI 1033115373
$2,764.25
in general payments reported to CMS, 2019-2025
17 companies · $1,083 in 2025
The $1,083 reported for 2025 was more than what 75% of Retina Specialist providers received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.16 · 2020: $74.54 · 2021: $94.91 · 2022: $83.35 · 2023: $451 · 2024: $928 · 2025: $1,083.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,421 · Education: $40.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,420.73 |
| Education | $40.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apellis Pharmaceuticals, INC. | $660.84 | 2023-2025 | Syfovre |
| Regeneron Healthcare Solutions, INC. | $592.84 | 2023-2025 | Eylea Hd, Eylea |
| Genentech USA, INC. | $371.99 | 2023-2025 | Vabysmo |
| Regeneron Pharmaceuticals, INC. | $248.15 | 2025 | Eylea Hd |
| Alcon Vision LLC | $245.65 | 2024 | Constellation |
| Allergan, INC. | $156.00 | 2019-2021 | |
| Astellas Pharma US INC | $118.58 | 2024-2025 | Izervay |
| Abbvie INC. | $84.09 | 2022-2024 | Ozurdex |
| Alimera Sciences, INC. | $77.55 | 2021-2023 | Iluvien |
| Mallinckrodt Hospital Products INC. | $61.61 | 2022-2024 | Acthar |
| Coherus Oncology, INC. | $34.41 | 2023 | |
| Bausch & Lomb Americas INC. | $31.49 | 2023-2025 | Xipere |
| Spark Therapeutics, INC. | $23.83 | 2022 | |
| Novartis Pharmaceuticals Corporation | $16.83 | 2019 | |
| Dompe US, INC. | $16.30 | 2024 | Oxervate |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $13.08 | 2024 | Purified Cortrophin Gel |
| Assertio Therapeutics, INC. | $11.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.